Clinical Trial Update: Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether pimecrolimus can reduce the need for topical steroids in pediatric patients with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED